BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of innovative adult stem cell therapeutics for debilitating neurodegenerative diseases, announced today that members of its executive team will present at the Northeast Amyotrophic Lateral Sclerosis (NEALS) Conference in Clearwater, Florida and the Cell & Gene Meeting on the Mesa 2018 Conference in La Jolla, California, both taking place today, October 3, 2018.
Chaim Lebovits, President & Chief Executive Officer, will also be attending the MidCap Investor Event® sponsored by CF&B Communication in Europe on October 8-9, 2018 in Paris, France, and will be available for one-on-one meetings with potential institutional investors. To schedule a meeting, please use the Contact link on BrainStorm’s website at www.brainstorm-cell.com.
NEALS Annual 2018 Conference
Poster entitled, “MicroRNA Changes in the NurOwn® Phase 2 ALS Randomized Clinical Trial: Relationship to Neuroprotection and Innate Immunity.”
Poster entitled, “MicroRNA Changes in the NurOwn® Phase 2 ALS Randomized Clinical Trial: Relationship to Neuroprotection and Innate Immunity.”
- Date: Wednesday, October 3, 2018
- Time: 3:45 pm to 5:45 pm Eastern Time (Clearwater, Florida)
- Location: Opal Foyer in the Opal Sands Resort, Clearwater, Florida
- Presenter: Ralph Kern, M.D., MHSc, Chief Operating Officer & Chief Medical Officer
- Key Academic Collaborators:
- Massachusetts General Hospital: James Berry, M.D. and Merit Cudkowicz, M.D.
- University of Massachusetts Medical School: Robert Brown, M.D. and Margaret Ayo Owegi, D.O.
- Mayo Clinic: Anthony Windebank, M.D. and Nathan Staff, M.D., Ph.D.
- For more information: https://goo.gl/zikHA2
Cell & Gene Meeting on the Mesa 2018 Conference
Scientific Workshop entitled, “Successful Strategies in the Design and Delivery of Cell & Gene Therapy Clinical Programs.”
Scientific Workshop entitled, “Successful Strategies in the Design and Delivery of Cell & Gene Therapy Clinical Programs.”
- Date: Wednesday, October 3, 2018
- Time: 7:15 am to 8:45 am Pacific Time (La Jolla, CA)
- Location: Estancia La Jolla Hotel, La Jolla, CA
- Workshop Panel Speakers:
- Peter Altman, Ph.D., President and CEO, BioCardia
- Blake Anson, Ph.D., Director, Strategic Alliances, Fujifilm Cellular Dynamics
- Robert Deans, Ph.D., Chief Technology Officer, BlueRock Therapeutics
- Gisèle Deblandre, Ph.D., Scientific and Project Management Director, MaSTherCell
- Felix Hsu, SVP and Head, Advanced Therapies Unit, WuXi AppTec
- Hardy Kagimoto, M.D., Chairman and CEO, Healios
- Dan Kaufman, M.D., Ph.D., Professor of Medicine, Division of Regenerative Medicine; Director of Cell Therapy, UC San Diego
- María Pascual, VP Regulatory Affairs and Corporate Quality, TiGenix
- Joseph Petroziello, VP, Scientific and Corporate Communications, BrainStorm Cell Therapeutics
- Edward Wirth, M.D., Ph.D., Chief Medical Officer, Asterias Biotherapeutics
- For more information: https://goo.gl/3M4L8b
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.